Company: SXTPW
Filing Date: 2025-03-27
Form Type: 10-K
Source: 0001013762-25-003343
Chunk: 30

Company: 60 DEGREES PHARMACEUTICALS, INC.
Filing Date: 2025-03-27
Form: 10-K
Item: Item 1
Chunk 30
---
 Dengue 
    Pending 
    Singapore 
    Pending 
      
    10201908089V 
    14-Mar-2034*
  
    Novel Dosing Regimens Of Celgosivir For The Treatment Of Dengue 
    9763921 
    US 
      
    9/19/2017 
    14/772,873 
    14-Mar-2034^
  
    Novel Dosing Regimens Of Celgosivir For The Treatment Of Dengue 
    10517854 
    US 
      
    12/31/2019 
    15/706,845 
    14-Mar-2034^
  
    Dosing Regimens Of Celgosivir For The Treatment Of Dengue 
    11219616 
    US 
      
    1/11/2022 
    16/725,387 
    14-Mar-2034^
  
    Novel Regimens Of Tafenoquine For Prevention Of Malaria In
    Malaria-Naïve Subjects 
    2015358566 
    Australia 

    2015358566 
    02-Dec-2035*
  
    Regimens Of Tafenoquine For Prevention Of Malaria In Malaria-Naïve
    Subjects 
    2968694 
    Canada 

    2968694 
    02-Dec-2035*
  
    Novel Regimens Of Tafenoquine For Prevention Of Malaria In
    Malaria-Naïve Subjects 
    10342791 
    US 
      
    7/9/2019 
    15/532,280 
    02-Dec-2035^
  
    Regimens Of Tafenoquine For Prevention Of Malaria In Malaria-Naive
    Subjects 
    10888558 
    US 
      
    1/12/2021 
    16/504,533 
    02-Dec-2035^
  
    Novel Regimens Of Tafenoquine For Prevention Of Malaria In
    Malaria-Naïve Subjects 
    Pending 
    Singapore 
    Pending 
      
    10201904908Q 
    02-Dec-2035*
  
    Novel Regimens Of Tafenoquine For Prevention Of Malaria In
    Malaria-Naïve Subjects 
    Pending